Dyne Operating Profit Margin vs Gross Profit Margin Analysis

DYN Stock  USD 25.73  0.12  0.47%   
Dyne Therapeutics financial indicator trend analysis is much more than just examining Dyne Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dyne Therapeutics is a good investment. Please check the relationship between Dyne Therapeutics Operating Profit Margin and its Gross Profit Margin accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.

Operating Profit Margin vs Gross Profit Margin

Operating Profit Margin vs Gross Profit Margin Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dyne Therapeutics Operating Profit Margin account and Gross Profit Margin. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Dyne Therapeutics' Operating Profit Margin and Gross Profit Margin is -0.24. Overlapping area represents the amount of variation of Operating Profit Margin that can explain the historical movement of Gross Profit Margin in the same time period over historical financial statements of Dyne Therapeutics, assuming nothing else is changed. The correlation between historical values of Dyne Therapeutics' Operating Profit Margin and Gross Profit Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Profit Margin of Dyne Therapeutics are associated (or correlated) with its Gross Profit Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit Margin has no effect on the direction of Operating Profit Margin i.e., Dyne Therapeutics' Operating Profit Margin and Gross Profit Margin go up and down completely randomly.

Correlation Coefficient

-0.24
Relationship DirectionNegative 
Relationship StrengthInsignificant

Operating Profit Margin

Gross Profit Margin

Most indicators from Dyne Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dyne Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.As of the 14th of December 2024, Issuance Of Capital Stock is likely to grow to about 126.9 M, while Selling General Administrative is likely to drop about 29.8 M.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation1.1M1.7M1.7M997.5K
Research Development121.3M142.8M210.8M221.3M

Dyne Therapeutics fundamental ratios Correlations

0.80.960.960.880.930.20.780.90.651.00.440.67-0.22-0.340.690.490.330.82-0.110.760.80.990.930.910.75
0.80.710.770.50.65-0.030.990.780.720.780.540.72-0.090.20.12-0.10.231.00.20.340.540.860.650.840.82
0.960.710.970.870.950.230.70.920.520.970.330.53-0.11-0.440.750.590.250.72-0.130.740.750.940.950.820.63
0.960.770.970.860.930.340.760.980.580.960.30.58-0.1-0.330.670.480.220.78-0.10.740.720.940.930.880.73
0.880.50.870.860.850.540.470.80.510.880.360.52-0.34-0.510.840.670.240.53-0.380.950.750.790.850.80.44
0.930.650.950.930.850.230.660.870.370.960.110.38-0.16-0.480.780.620.280.66-0.080.790.780.911.00.740.69
0.2-0.030.230.340.540.23-0.060.40.120.18-0.050.1-0.33-0.120.360.21-0.240.0-0.530.620.220.080.230.28-0.08
0.780.990.70.760.470.66-0.060.770.630.770.450.63-0.050.20.1-0.10.210.990.260.320.510.850.660.780.82
0.90.780.920.980.80.870.40.770.590.890.270.59-0.04-0.230.570.370.160.79-0.060.670.640.890.870.870.72
0.650.720.520.580.510.370.120.630.590.590.841.0-0.280.140.18-0.020.310.73-0.190.340.510.670.370.880.59
1.00.780.970.960.880.960.180.770.890.590.390.6-0.2-0.380.710.530.320.79-0.10.770.80.980.960.880.74
0.440.540.330.30.360.11-0.050.450.270.840.390.82-0.260.150.05-0.070.20.54-0.180.180.30.440.110.630.22
0.670.720.530.580.520.380.10.630.591.00.60.82-0.270.110.20.010.390.73-0.170.350.530.680.380.890.6
-0.22-0.09-0.11-0.1-0.34-0.16-0.33-0.05-0.04-0.28-0.2-0.26-0.27-0.01-0.2-0.010.07-0.110.8-0.43-0.64-0.16-0.16-0.260.01
-0.340.2-0.44-0.33-0.51-0.48-0.120.2-0.230.14-0.380.150.11-0.01-0.83-0.92-0.240.190.28-0.53-0.24-0.26-0.48-0.1-0.03
0.690.120.750.670.840.780.360.10.570.180.710.050.2-0.2-0.830.950.240.14-0.40.850.640.60.780.480.27
0.49-0.10.590.480.670.620.21-0.10.37-0.020.53-0.070.01-0.01-0.920.950.24-0.08-0.280.690.410.410.620.260.13
0.330.230.250.220.240.28-0.240.210.160.310.320.20.390.07-0.240.240.240.230.210.170.230.340.280.360.35
0.821.00.720.780.530.660.00.990.790.730.790.540.73-0.110.190.14-0.080.230.170.370.560.870.660.850.82
-0.110.2-0.13-0.1-0.38-0.08-0.530.26-0.06-0.19-0.1-0.18-0.170.80.28-0.4-0.280.210.17-0.44-0.5-0.02-0.08-0.150.26
0.760.340.740.740.950.790.620.320.670.340.770.180.35-0.43-0.530.850.690.170.37-0.440.690.660.790.650.39
0.80.540.750.720.750.780.220.510.640.510.80.30.53-0.64-0.240.640.410.230.56-0.50.690.770.780.710.47
0.990.860.940.940.790.910.080.850.890.670.980.440.68-0.16-0.260.60.410.340.87-0.020.660.770.910.910.82
0.930.650.950.930.851.00.230.660.870.370.960.110.38-0.16-0.480.780.620.280.66-0.080.790.780.910.740.69
0.910.840.820.880.80.740.280.780.870.880.880.630.89-0.26-0.10.480.260.360.85-0.150.650.710.910.740.75
0.750.820.630.730.440.69-0.080.820.720.590.740.220.60.01-0.030.270.130.350.820.260.390.470.820.690.75
Click cells to compare fundamentals

Dyne Therapeutics Account Relationship Matchups

Dyne Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets16.4M353.3M425.7M306.3M165.1M156.8M
Short Long Term Debt Total8.4B3.4M32.6M30.5M27.4M26.0M
Other Current Liab1.1M7.5M16.9M13.6M18.7M17.8M
Total Current Liabilities2.4M11.0M28.7M28.1M51.1M48.5M
Total Stockholder Equity14.0M342.4M368.2M252.4M91.3M86.7M
Property Plant And Equipment Net1.5M1.9M41.0M38.4M33.4M31.7M
Net Debt(14.6M)(300.9M)(168.2M)(141.7M)(94.2M)(89.5M)
Accounts Payable1.3M3.4M4.0M5.3M22.9M21.8M
Cash14.6M300.9M200.8M172.1M121.6M115.5M
Non Current Assets Total1.7M8.0M43.3M50.3M35.7M33.9M
Non Currrent Assets Other191K3.8M2.3M9.6M2.3M2.2M
Cash And Short Term Investments14.6M345.3M376.6M256.0M123.1M116.9M
Common Stock Shares Outstanding45.4M14.4M50.9M52.0M59.7M56.7M
Liabilities And Stockholders Equity16.4M353.3M425.7M306.3M165.1M156.8M
Non Current Liabilities Total42K3.4M28.7M25.9M22.7M21.6M
Other Current Assets127K7.5M11.6M9.6M6.3M6.0M
Other Stockholder Equity6.4M421.6M596.9M649.5M723.8M687.6M
Total Liab2.4M11.0M57.5M54.0M73.8M70.1M
Property Plant And Equipment Gross1.5M1.9M42.9M42.0M38.7M36.7M
Total Current Assets14.8M345.3M382.4M256.0M129.4M122.9M
Accumulated Other Comprehensive Income0.0(27K)(269K)(571K)(656.7K)(689.5K)
Retained Earnings(19.7M)(79.2M)(228.5M)(396.6M)(632.5M)(664.1M)
Net Tangible Assets(13.4M)342.4M368.2M252.4M290.2M207.8M
Net Invested Capital(13.4M)342.4M368.2M252.4M91.3M86.7M
Net Working Capital12.4M338.1M353.7M237.5M78.3M74.4M
Property Plant Equipment1.5M1.9M41.0M38.4M44.2M46.4M

Pair Trading with Dyne Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Dyne Stock

  0.66VALN Valneva SE ADRPairCorr
  0.65ERNA Eterna TherapeuticsPairCorr

Moving against Dyne Stock

  0.78GILD Gilead Sciences Sell-off TrendPairCorr
  0.73BMY Bristol Myers SquibbPairCorr
  0.66ESPR Esperion TherapeuticsPairCorr
  0.46DYAI Dyadic InternationalPairCorr
  0.34DNA Ginkgo Bioworks HoldingsPairCorr
The ability to find closely correlated positions to Dyne Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne Therapeutics to buy it.
The correlation of Dyne Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Dyne Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dyne Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dyne Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dyne Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.60)
Return On Assets
(0.40)
Return On Equity
(0.69)
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.